Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

67.46 +0.23 (+0.34%)
Streaming Delayed Price Updated: 3:53 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Edwards Lifesciences

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
What 8 Analyst Ratings Have To Say About Edwards Lifesciences
Within the last quarter, Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings: 
Via Benzinga
HC Wainwright Cuts Price Target On This Stock By 50%? Also This Analyst Slashes PT On Cisco
Barclays cut the price target on Cisco Systems, Inc. (NASDAQ: CSCO) from $56 to $46. Barclays analyst Tim Long downgraded the stock from Overweight to Equal-Weight. Cisco shares rose 0.1% to $41.61 in... 
Via Benzinga
Weekend Stock Spotlight: Netflix, Meta, NVIDIA, Disney And The Battle For The Stable Coin Market
Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read. 
Via Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
Via Benzinga
Edwards Lifesciences Shares Slide As Q2 Results Miss Expectations, Lowers FY22 Sales Outlook
Via Benzinga
Expert Ratings for Edwards Lifesciences
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: 
Via Benzinga
Where Edwards Lifesciences Stands With Analysts
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: 
Via Benzinga
FDA Approves Edwards Lifesciences' PASCAL Precision Transcatheter Valve Repair System For Most Frequent Cardiovascular Disorder
Via Benzinga
Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics
Agilent managed to stave off challenges due to Covid and exchange rates for a big beat. 
Via Investor's Business Daily
Edwards Lifesciences Whale Trades Spotted
Someone with a lot of money to spend has taken a bullish stance on Edwards Lifesciences (NYSE:EW). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Analyzing Edwards Lifesciences's Short Interest
Edwards Lifesciences's (NYSE:EW) short percent of float has risen 6.93% since its last report. The company recently reported that it has 6.66 million shares sold short, which is 1... 
Via Benzinga
Here's How Much $100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.8%. Currently, Edwards Lifesciences has a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
  
Via Benzinga
Roku, Intel And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! It's time to start off Friday with a breakdown of the biggest pre-market stock movers traders need to know about! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
Recap: Edwards Lifesciences Q2 Earnings
Edwards Lifesciences (NYSE:EW) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Edwards Lifesciences Wipes Out Regular-Session Gains On 2022 Guidance Cut
Edwards Lifesciences now expects sales to grow just 10% on an underlying basis. Exchange rates and hospital staffing are challenging growth. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Edwards Lifesciences's (NYSE:EW) short percent of float has fallen 64.56% since its last report. The company recently reported that it has 6.21 million shares sold short, which is... 
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 17.08% on an annualized basis producing an average annual return of 23.24%. Currently, Edwards Lifesciences has a... 
Via Benzinga
Analyzing Edwards Lifesciences's Short Interest
Edwards Lifesciences's (NYSE:EW) short percent of float has risen 166.36% since its last report. The company recently reported that it has 5.87 million shares sold short, which is... 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $600 Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 7.85% on an annualized basis producing an average annual return of 18.65%. Currently, Edwards Lifesciences has a... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Jim Cramer Shares His Takes On Marathon Oil, T Rowe Price Group And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Marathon Oil Corp (NYSE: MRO) because he likes the oils. But he recommended not getting greedy. 
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Edwards Lifesciences's (NYSE:EW) short percent of float has risen 6.33% since its last report. The company recently reported that it has 5.15 million shares sold short, which is 0... 
Via Benzinga
Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 16.51% on an annualized basis producing an average annual return of 22.72%. Currently, Edwards Lifesciences has a... 
Via Benzinga
7 Growth Stocks That Analysts Love Right Now
These growth stocks are receiving buy ratings and significantly higher price targets from analysts, making them ideal names to consider. 
Via InvestorPlace
Why Jim Cramer Prefers These 2 Semiconductor Stocks
On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc. (NASDAQ: SOFI) has been getting destroyed. 
Via Benzinga
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
The Nasdaq hit its lowest level since 2020. Apple and Facebook led key earnings. 
Via Investor's Business Daily
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.